Careers  |  Sign In  |  Register  |   Twitter

Latest in Internal Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Once-daily lixisenatide effective as monotherapy for DM2

NEW YORK (Reuters Health) – The investigational GLP-1 receptor antagonist lixisenatide significantly reduces postprandial glucose excursions and HbA1c in patients with type 2 diabetes who have not been treated with any other glucose-lowering agent, researchers report in Diabetes Care online March 19. “No...

Reuters Health • The Doctor's Channel Daily Newscast

Skip the antibiotic in cases of acute sinusitis: report

NEW YORK (Reuters Health) – Antibiotic therapy in the first week of acute mild to moderate sinusitis is not worth it and should be avoided, conclude the authors of a report published in Archives of Internal Medicine. Sinusitis is one of the most common diagnoses made in primary care, accounting for 20...

Reuters Health • The Doctor's Channel Daily Newscast

Substernal goiter may be an under-recognized cause of OSA

NEW YORK (Reuters Health) – Goiter should be considered in the differential diagnosis of positional dyspnea, even in patients without obvious thyroid enlargement, according to a new retrospective analysis published online March 19 in the Archives of Surgery. “People are more symptomatic from thyroid...